Latest Akorn Inc (AKRX) Headlines Most-Recent B
Post# of 77
Posted On: 03/12/2014 5:38:30 PM
Latest Akorn Inc (AKRX) Headlines
Most-Recent Breakouts Among IBD 50 Stocks Mixed So Far
at Investor's Business Daily - Fri Mar 07, 5:50PM CST
With most IBD 50 stocks extended from buy points, few choices remain for new purchases, and the most recent breakouts are having mixed results. A few stocks that broke out in the past couple of weeks are above their buy points and acting well enough....
Stocks on the Radar: Akorn, Central European Media Enterprises, Denny's, bebe stores, and Eni SpA
PR Newswire - Tue Mar 04, 9:25AM CST
The US markets ended on a negative sentiment on Monday, March 03, 2014, with the NASDAQ Composite closing at 4,277.30, down 0.72%; the Dow Jones Industrial Average ending the session at 16,168.03, down 0.94%, and S&P 500 edging 0.74% lower to close at 1,845.73. The losses were broad based with all ten sectors edging lower. Investor-Edge.com has initiated coverage on the following equities: Akorn Inc. (NASDAQ: AKRX), Central European Media Enterprises Ltd (NASDAQ: CETV), Denny's Corp. (NASDAQ: DENN), bebe stores inc. (NASDAQ: BEBE), and Eni SpA (NYSE: E) which witnessed unusually high trading volumes in the previous trading session. Free report on these five companies can be accessed at
Harwood Feffer LLP Announces Investigation of Akorn, Inc.
PR Newswire - Mon Mar 03, 8:00PM CST
NEW YORK, March 3, 2014 /PRNewswire/-- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) and its board of directors concerning whether the board has breached its fiduciary duties to shareholders or violated the federal securities laws.
Akorn's guidance disappoints
at Investor's Business Daily - Mon Mar 03, 5:36PM CST
The specialty drug maker's Q4 EPS rose 7.7% to 14 cents, in line with views. Sales rose 19% to $85 mil, above analysts' estimates for $83 mil. For all '13, sales rose 24% to $318 mil and net income climbed 6% to 55 cents a share. It guided '14 sales...
Akorn Guidance Worries Street As Strategy Hits Delays
at Investor's Business Daily - Mon Mar 03, 4:30PM CST
Specialty drugmaker Akorn's Q4 earnings met estimates Monday, but its 2014 guidance and a new accounting problem halted the IBD 50 stock dead in its tracks. Akorn (AKRX) said profit totaled 14 cents a share, up a penny from the year-earlier quarter...
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc.
PR Newswire - Mon Mar 03, 3:52PM CST
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Akorn, Inc. ("Akorn" or the "Company") (NasdaqGS: AKRX). Such investors are advised to contact Peretz Bronstein or his investor Relation's coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484.
Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 03, 12:34PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Stocks Down Hard But Up Slightly From Session Lows
at Investor's Business Daily - Mon Mar 03, 12:33PM CST
Stocks were off intraday lows but still down hard in afternoon trading as Russia's military action in Ukraine's Crimea region continued to stoke geopolitical fears. The Nasdaq was down 1.2%, the Dow 1.1% and the S&P 500 0.9%. Volume was mixed, with...
Why Akorn, Inc. Shares Were Cracked
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 03, 12:22PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Akorn , a branded and generic developer of...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akorn, Inc. - AKRX
PR Newswire - Mon Mar 03, 12:07PM CST
Pomerantz LLP is investigating claims on behalf of investors of Akorn, Inc. ("Akorn" or the "Company") (NasdaqGS: AKRX) (CUSIP: 009728106). Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.
Why Akorn (AKRX) Is Down Today
at The Street - Mon Mar 03, 12:06PM CST
Akorn (AKRX) plunges after the generic pharmaceutical company issues first-quarter guidance that comes up short of analysts' expectations.
Stocks Edge Lower, Trade Mixed; Oil, Bonds, Dollar Rising
at Investor's Business Daily - Mon Mar 03, 9:33AM CST
Solid consumer spending and income numbers weren't enough to help stocks early Monday, as the major indexes skidded on Russia's military action in Ukraine. The Dow Jones industrial average fell 0.8% while the Nasdaq and the S&P 500 backed off 0.7%....
Akorn Q4 Meets But Guidance Disappoints, Stock Down
at Investor's Business Daily - Mon Mar 03, 9:07AM CST
Specialty drugmaker Akorn (AKRX) Monday reported a Q4 in line with estimates, but it guided 2014 below expectations and shares plummeted 15% in early trading in the stock market today. The company said profit totaled 14 cents a share, up a penny from...
Akorn, Inc. Announces Fourth Quarter 2013 Earnings Release And Conference Call Information
PR Newswire - Mon Mar 03, 6:45AM CST
Akorn, Inc. (NASDAQ: AKRX) will host a conference call on Monday, March 3, 2014, to discuss fourth quarter 2013 results followed by a Q&A session. The company will release earnings the same day before the market opens.
Akorn Reports 2013 Fourth Quarter and Year-End Financial Results
Business Wire - Mon Mar 03, 5:00AM CST
Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for the fourth quarter and year-ended December 31, 2013.
Qihoo, WuXi, Akorn Among Last IBD 50 Earnings Reports
at Investor's Business Daily - Sat Mar 01, 7:02AM CST
Sometimes the best is saved for last. Earnings season is winding down, but leaders like Qihoo 360 Technology (QIHU) and Akorn (AKRX) are on tap. They are joined by fellow IBD 50 companies WuXi PharmaTech (WX) and Gentherm (THRM) that are slated to...
2 Weak Breakouts, A Few Sell-Offs For The IBD 50
at Investor's Business Daily - Fri Feb 28, 5:25PM CST
A couple of IBD 50 stocks broke out Friday, as the list of top-performing stocks also suffered at the hands of a few components that tumbled badly. The breakouts belonged to Signature Bank (SBNY) and Chipotle Mexican Grill (CMG). Chipotle saw a...
Akorn, Questcor, Parexel Among Top Medical Small Caps
at Investor's Business Daily - Thu Feb 27, 7:02AM CST
The health care industry is rapidly changing with new advances in medicine. Many of the most promising novel advancements are coming from smaller companies, which are more nimble and quicker to change. Medicine and health care-related stocks Akorn...
Akorn Up 15.6% Since SmarTrend Uptrend Call (AKRX)
Comtex SmarTrend(R) - Wed Feb 26, 9:32AM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on February 11th, 2014 at $23.61. In approximately 2 weeks, Akorn has returned 15.57% as of today's recent price of $27.28.
Akorn (AKRX) in Focus: Stock Moves 5.0% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:21AM CST
Akorn, Inc. (AKRX) was a big mover last session, as the company saw its shares rise by over 5% on the day.
Most-Recent Breakouts Among IBD 50 Stocks Mixed So Far
at Investor's Business Daily - Fri Mar 07, 5:50PM CST
With most IBD 50 stocks extended from buy points, few choices remain for new purchases, and the most recent breakouts are having mixed results. A few stocks that broke out in the past couple of weeks are above their buy points and acting well enough....
Stocks on the Radar: Akorn, Central European Media Enterprises, Denny's, bebe stores, and Eni SpA
PR Newswire - Tue Mar 04, 9:25AM CST
The US markets ended on a negative sentiment on Monday, March 03, 2014, with the NASDAQ Composite closing at 4,277.30, down 0.72%; the Dow Jones Industrial Average ending the session at 16,168.03, down 0.94%, and S&P 500 edging 0.74% lower to close at 1,845.73. The losses were broad based with all ten sectors edging lower. Investor-Edge.com has initiated coverage on the following equities: Akorn Inc. (NASDAQ: AKRX), Central European Media Enterprises Ltd (NASDAQ: CETV), Denny's Corp. (NASDAQ: DENN), bebe stores inc. (NASDAQ: BEBE), and Eni SpA (NYSE: E) which witnessed unusually high trading volumes in the previous trading session. Free report on these five companies can be accessed at
Harwood Feffer LLP Announces Investigation of Akorn, Inc.
PR Newswire - Mon Mar 03, 8:00PM CST
NEW YORK, March 3, 2014 /PRNewswire/-- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX) and its board of directors concerning whether the board has breached its fiduciary duties to shareholders or violated the federal securities laws.
Akorn's guidance disappoints
at Investor's Business Daily - Mon Mar 03, 5:36PM CST
The specialty drug maker's Q4 EPS rose 7.7% to 14 cents, in line with views. Sales rose 19% to $85 mil, above analysts' estimates for $83 mil. For all '13, sales rose 24% to $318 mil and net income climbed 6% to 55 cents a share. It guided '14 sales...
Akorn Guidance Worries Street As Strategy Hits Delays
at Investor's Business Daily - Mon Mar 03, 4:30PM CST
Specialty drugmaker Akorn's Q4 earnings met estimates Monday, but its 2014 guidance and a new accounting problem halted the IBD 50 stock dead in its tracks. Akorn (AKRX) said profit totaled 14 cents a share, up a penny from the year-earlier quarter...
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc.
PR Newswire - Mon Mar 03, 3:52PM CST
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Akorn, Inc. ("Akorn" or the "Company") (NasdaqGS: AKRX). Such investors are advised to contact Peretz Bronstein or his investor Relation's coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484.
Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 03, 12:34PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Stocks Down Hard But Up Slightly From Session Lows
at Investor's Business Daily - Mon Mar 03, 12:33PM CST
Stocks were off intraday lows but still down hard in afternoon trading as Russia's military action in Ukraine's Crimea region continued to stoke geopolitical fears. The Nasdaq was down 1.2%, the Dow 1.1% and the S&P 500 0.9%. Volume was mixed, with...
Why Akorn, Inc. Shares Were Cracked
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 03, 12:22PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Akorn , a branded and generic developer of...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akorn, Inc. - AKRX
PR Newswire - Mon Mar 03, 12:07PM CST
Pomerantz LLP is investigating claims on behalf of investors of Akorn, Inc. ("Akorn" or the "Company") (NasdaqGS: AKRX) (CUSIP: 009728106). Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.
Why Akorn (AKRX) Is Down Today
at The Street - Mon Mar 03, 12:06PM CST
Akorn (AKRX) plunges after the generic pharmaceutical company issues first-quarter guidance that comes up short of analysts' expectations.
Stocks Edge Lower, Trade Mixed; Oil, Bonds, Dollar Rising
at Investor's Business Daily - Mon Mar 03, 9:33AM CST
Solid consumer spending and income numbers weren't enough to help stocks early Monday, as the major indexes skidded on Russia's military action in Ukraine. The Dow Jones industrial average fell 0.8% while the Nasdaq and the S&P 500 backed off 0.7%....
Akorn Q4 Meets But Guidance Disappoints, Stock Down
at Investor's Business Daily - Mon Mar 03, 9:07AM CST
Specialty drugmaker Akorn (AKRX) Monday reported a Q4 in line with estimates, but it guided 2014 below expectations and shares plummeted 15% in early trading in the stock market today. The company said profit totaled 14 cents a share, up a penny from...
Akorn, Inc. Announces Fourth Quarter 2013 Earnings Release And Conference Call Information
PR Newswire - Mon Mar 03, 6:45AM CST
Akorn, Inc. (NASDAQ: AKRX) will host a conference call on Monday, March 3, 2014, to discuss fourth quarter 2013 results followed by a Q&A session. The company will release earnings the same day before the market opens.
Akorn Reports 2013 Fourth Quarter and Year-End Financial Results
Business Wire - Mon Mar 03, 5:00AM CST
Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for the fourth quarter and year-ended December 31, 2013.
Qihoo, WuXi, Akorn Among Last IBD 50 Earnings Reports
at Investor's Business Daily - Sat Mar 01, 7:02AM CST
Sometimes the best is saved for last. Earnings season is winding down, but leaders like Qihoo 360 Technology (QIHU) and Akorn (AKRX) are on tap. They are joined by fellow IBD 50 companies WuXi PharmaTech (WX) and Gentherm (THRM) that are slated to...
2 Weak Breakouts, A Few Sell-Offs For The IBD 50
at Investor's Business Daily - Fri Feb 28, 5:25PM CST
A couple of IBD 50 stocks broke out Friday, as the list of top-performing stocks also suffered at the hands of a few components that tumbled badly. The breakouts belonged to Signature Bank (SBNY) and Chipotle Mexican Grill (CMG). Chipotle saw a...
Akorn, Questcor, Parexel Among Top Medical Small Caps
at Investor's Business Daily - Thu Feb 27, 7:02AM CST
The health care industry is rapidly changing with new advances in medicine. Many of the most promising novel advancements are coming from smaller companies, which are more nimble and quicker to change. Medicine and health care-related stocks Akorn...
Akorn Up 15.6% Since SmarTrend Uptrend Call (AKRX)
Comtex SmarTrend(R) - Wed Feb 26, 9:32AM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on February 11th, 2014 at $23.61. In approximately 2 weeks, Akorn has returned 15.57% as of today's recent price of $27.28.
Akorn (AKRX) in Focus: Stock Moves 5.0% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:21AM CST
Akorn, Inc. (AKRX) was a big mover last session, as the company saw its shares rise by over 5% on the day.
(0)
(0)Akorn Inc. (AKRXQ) Stock Research Links
Scroll down for more posts ▼